Table 7.

Ongoing clinical trials for evaluation of anti-rheumatic drugs ((https://clinicaltrials.gov/ct2/results).

Clinical Trial Number	Study Description	Phase	Dose	Location
NCT04356937	Evaluating the Efficacy of Tocilizumab	3	8 mg	United States
NCT04345445	Clinical trial Study for Evaluating if Tocilizumab and corticosteroids are efficacious for coronavirus infection	3	8 mg	Malaysia
NCT04317092	Evaluating the Efficacy of Tocilizumab	2	8 mg	Italy
NCT04358614	Baricitinib Therapy in COVID-19	2,3	4 mg	Italy
NCT04340232	Studying the Safety and Efficacy of Baricitinib	2,3	2 mg	United States
NCT04346147	Studying the Safety and Efficacy of Baricitinib	2	4 mg	Spain
NCT04325633	Evaluation of the Efficacy when Naproxen is added in treating of Critically Ill Patients	3	250 mg twice daily	Not Specified